Cabazitaxel Plus Prednisone for Patients With Metastatic Castration-resistant Prostate Cancer Previously Treated With a Docetaxel-containing Regimen - Interim Analysis Results From an Ongoing Compassionate-use Programme
Yazar
Gschwend, J.
Ozguroglu, M.
Albers, P.
Ecstein-Fraisse, E.
Bavbek, S.
Heidenreich, A.
Scholz, H. J.
van Oort, I.
Mueller, S.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]